Related Experiment Video
Updated: Mar 14, 2026

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
Classifying skin diseases: Until where should we go?
1Université Paris 5 Descartes, Department of Dermatology, Hôpital Cochin, ApHp and Inserm UMRS938, Paris, France.
Abstract:
New molecular mapping techniques appear to allow clinicians to design treatments in some cases of resisting cancers. Such sensitive analysis were already able to depict molecular pathways of several inflammatory skin diseases. An accompanying article by Garzorz-Stark et al. show how these tools could improve the classification of skin inflammatory diseases now based on clinical and pathological features. At last, the final aim of these tools is to predict treatment response in a patient. The utility of "precision" or personalized medicine in cutaneous inflammatory diseases could join the furrow drawn in cancer.
Insights
New molecular mapping techniques enable personalized medicine for inflammatory skin diseases, improving classification and predicting treatment response, similar to advancements in cancer care.
Area of Science:
- Dermatology
- Molecular Biology
- Genomics
Background:
- Current classification of inflammatory skin diseases relies on clinical and pathological features.
- Molecular mapping techniques offer sensitive analysis of molecular pathways.
- Advancements in precision medicine are transforming cancer treatment.
Discussion:
- Molecular mapping can refine the classification of inflammatory skin diseases beyond current standards.
- These techniques elucidate specific molecular pathways involved in skin inflammation.
- The integration of molecular data aids in developing targeted therapies.
Key Insights:
- Sensitive molecular analysis can depict disease pathways in inflammatory skin conditions.
- Improved classification of skin diseases is achievable using molecular tools.
- Predicting patient treatment response is a key goal for personalized dermatology.
Outlook:
- Personalized medicine approaches hold significant promise for cutaneous inflammatory diseases.
- Molecular mapping could lead to novel therapeutic strategies.
- The future of dermatology may involve routine use of molecular diagnostics for treatment design.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Stages of Infection
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

